Dublin Core PKP Metadata Items Metadata for this Document
1. Title Title of document Manufacturing the truth: From designing clinical trials to publishing trial data
2. Creator Author's name, affiliation, country Margaret Whitstock; School of Humanities and Social Sciences, Faculty of Arts and Education, Deakin University, Australia
3. Subject Discipline(s)
3. Subject Keyword(s)
4. Description Abstract This paper expands on some of the points made by Deepak Natarajan on techniques used in designing clinical trials of new drugs to ensure favourable outcomes. It also considers the nexus between the manufacturers of new drugs and the publishers of medical journals in which edited versions of these favourable outcomes are presented to the medical fraternity. The argument will be illustrated by referring to the clinical trials of rofecoxib (Vioxx®) and etoricoxib (Arcoxia®). Both these drugs are COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) manufactured by Merck & Co. Because of the unparalleled access to Merck's internal confidential documents, due to the subpoenaing of these documents by government and private individuals in civil and criminal actions, we are still learning about the company's unconscionable acts. What we learn can inform our judgement concerning published reports of both new and old drugs.
5. Publisher Organizing agency, location Forum for Medical Ethics Society
6. Contributor Sponsor(s)
7. Date (YYYY-MM-DD) 2017-11-14
8. Type Status & genre
8. Type Type
9. Format File format HTML , PDF
10. Identifier Uniform Resource Identifier http://ijme.in/articles/manufacturing-the-truth-from-designing-clinical-trials-to-publishing-trial-data/
11. Source Title; vol., no. (year) Indian Journal of Medical Ethics;: Medical miracles or tools of objectification?
12. Language English=en en
13. Relation Supp. Files
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
15. Rights Copyright and permissions

All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.